SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Damon Pham who wrote (418)4/29/1997 3:44:00 PM
From: Damon Pham   of 849
 
This is from the Proxy Statement for the annual meeting which all of you should be getting soon.

*********
AMOUNT AND
NATURE OF
BENEFICIAL
PERCENT
NAME OWNERSHIP(1) OF CLASS (2)
------------- ----------- ------------
Stephen D. Chubb 375,042 2.3%
David L. Corbet 96,229 *
Ying-Jye Wu 50,008 *
Leslie R. Teso 18,384 *
J. Robert Buchanan 12,500 *
Thomas Morse 695,440 4.3%
David Rubinfien 37,849 *
T. Stephen Thompson 29,899 *
C. William Zadel 15,550 *

Forstmann-Leff Associates, Inc.
1,785,300 11.1%

All executive officers and directors as a group
1,330,901 8.1%
-----------------------------
* Indicates less than 1%

Stephen D. Chubb 53 Chairman, Director and CEO
David L. Corbet 43 Director, President and COO
Leslie R. Teso 38 VP, Finance, Treasurer and Secretary
Ying-Jye Wu 48 Vice President, Product Development
J. Robert Buchanan 69 Director
Thomas R. Morse 45 Director
David Rubinfien 75 Director
T. Stephen Thompson 49 Director
C. William Zadel 53 Director
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext